Cetera Investment Advisers Has $40.13 Million Holdings in Cardinal Health, Inc. $CAH

Cetera Investment Advisers raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.5% in the first quarter, Holdings Channel reports. The firm owned 189,901 shares of the company’s stock after buying an additional 14,907 shares during the period. Cetera Investment Advisers’ holdings in Cardinal Health were worth $40,128,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in CAH. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health in the fourth quarter worth approximately $26,000. Bank of Jackson Hole Trust acquired a new stake in Cardinal Health in the fourth quarter valued at approximately $27,000. Indiana Trust & Investment Management Co bought a new stake in Cardinal Health in the first quarter worth approximately $29,000. Palladiem LLC bought a new stake in Cardinal Health in the fourth quarter worth approximately $28,000. Finally, Elyxium Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth $34,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.9%

NYSE CAH opened at $227.96 on Friday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21. The company has a fifty day simple moving average of $219.98 and a 200 day simple moving average of $214.43. The company has a market cap of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.12 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the previous year, the business earned $2.35 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were given a dividend of $0.5158 per share. The ex-dividend date of this dividend was Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.50%.

Analyst Ratings Changes

CAH has been the topic of a number of recent research reports. Bank of America raised their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, July 2nd. Wells Fargo & Company lowered their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. Finally, UBS Group upped their price target on Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $251.73.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.